Flinton Capital Management LLC trimmed its position in shares of Danaher Co. (NYSE:DHR) by 9.0% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 474,232 shares of the conglomerate’s stock after selling 46,920 shares during the period. Danaher accounts for 1.5% of Flinton Capital Management LLC’s investment portfolio, making the stock its 12th biggest holding. Flinton Capital Management LLC owned 0.07% of Danaher worth $46,797,000 at the end of the most recent reporting period.
Several other large investors also recently modified their holdings of DHR. Mount Yale Investment Advisors LLC acquired a new stake in shares of Danaher during the 1st quarter valued at $103,000. IMS Capital Management acquired a new stake in shares of Danaher in the 2nd quarter valued at $107,000. BerganKDV Wealth Management LLC acquired a new stake in shares of Danaher in the 2nd quarter valued at $111,000. Braun Bostich & Associates Inc. lifted its stake in shares of Danaher by 506.4% in the 2nd quarter. Braun Bostich & Associates Inc. now owns 1,225 shares of the conglomerate’s stock valued at $121,000 after purchasing an additional 1,023 shares during the last quarter. Finally, Zions Bancorporation acquired a new stake in shares of Danaher in the 1st quarter valued at $123,000. 76.95% of the stock is owned by institutional investors.
Several research firms recently issued reports on DHR. Zacks Investment Research lowered shares of Danaher from a “buy” rating to a “hold” rating in a research note on Tuesday, July 24th. Bank of America set a $113.00 price objective on shares of Danaher and gave the company a “buy” rating in a research note on Thursday, July 19th. Royal Bank of Canada lifted their price objective on shares of Danaher to $107.00 and gave the company a “positive” rating in a research note on Thursday, July 19th. They noted that the move was a valuation call. Finally, Morgan Stanley lifted their price objective on shares of Danaher from $113.00 to $120.00 and gave the company an “overweight” rating in a research note on Friday, July 13th. Two equities research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $108.31.
Danaher stock opened at $103.55 on Wednesday. The firm has a market cap of $72.45 billion, a price-to-earnings ratio of 23.91, a PEG ratio of 1.98 and a beta of 1.03. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.50 and a quick ratio of 1.07. Danaher Co. has a fifty-two week low of $82.81 and a fifty-two week high of $106.08.
Danaher (NYSE:DHR) last released its earnings results on Thursday, July 19th. The conglomerate reported $1.15 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.09 by $0.06. The firm had revenue of $4.98 billion during the quarter, compared to analyst estimates of $4.91 billion. Danaher had a net margin of 13.84% and a return on equity of 11.55%. The business’s revenue was up 10.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.99 EPS. equities analysts forecast that Danaher Co. will post 4.49 earnings per share for the current fiscal year.
In other Danaher news, SVP Robert S. Lutz sold 14,555 shares of the business’s stock in a transaction on Tuesday, July 24th. The shares were sold at an average price of $103.93, for a total transaction of $1,512,701.15. Following the completion of the transaction, the senior vice president now owns 18,044 shares of the company’s stock, valued at approximately $1,875,312.92. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Daniel L. Comas sold 77,407 shares of the business’s stock in a transaction on Thursday, July 26th. The stock was sold at an average price of $103.93, for a total transaction of $8,044,909.51. Following the transaction, the chief financial officer now directly owns 135,218 shares of the company’s stock, valued at approximately $14,053,206.74. The disclosure for this sale can be found here. In the last three months, insiders have sold 299,961 shares of company stock valued at $30,619,691. Company insiders own 11.90% of the company’s stock.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.
Recommended Story: What is a Stop Order?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.